Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
clopidogrel spirig hc 75mg compresse rivestite con film
spirig healthcare ag - clopidogrelum - compresse rivestite con film - clopidogrelum 75 mg ut clopidogreli hydrogenosulfas, excipiens pro compresso obducto. - antiaggreganti piastrinici - synthetika
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
irbesartan e idroclorotiazide pensa
towa pharmaceutical s.p.a. - irbesartan e diuretici - irbesartan e diuretici
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
aproxxamlo
sanofi s.r.l. - irbesartan e amlodipina - irbesartan e amlodipina
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
aubagio 14 mg qod compresse rivestite con film
sanofi-aventis (suisse) sa - teriflunomidum - compresse rivestite con film - comprimé pelliculé: teriflunomidum 14 mg, color.: e 132, excipiens pro compresso obducto. - traitement des patients adultes et des patients pédiatriques de 10 ans et plus présentant des formes récurrentes-rémittentes de sclérose en plaques (sep) - synthetika
Unione Europea -
italiano -
EMA (European Medicines Agency)
yselty
theramex ireland limited - linzagolix choline - leiomioma - ormoni ipofisari e ipotalamici e analoghi - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
Unione Europea -
italiano -
EMA (European Medicines Agency)
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
Unione Europea -
italiano -
EMA (European Medicines Agency)
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori selettivi immunosoppressori - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
teriflunomide teva
teva b.v. - teriflunomide - teriflunomide
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
teriflunomide medac
medac pharma srl - teriflunomide - teriflunomide
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
clefirem
bausch health ireland limited - teriflunomide - teriflunomide